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Background. Previous studies of the dimensional structure of panic attack symptoms have mostly identified a respira-
tory and a vestibular/mixed somatic dimension. Evidence for additional dimensions such as a cardiac dimension and the
allocation of several of the panic attack symptom criteria is less consistent. Clarifying the dimensional structure of the
panic attack symptoms should help to specify the relationship of potential risk factors like anxiety sensitivity and fear
of suffocation to the experience of panic attacks and the development of panic disorder.
Method. In an outpatient multicentre study 350 panic patients with agoraphobia rated the intensity of each of the ten
DSM-IV bodily symptoms during a typical panic attack. The factor structure of these data was investigated with non-
linear confirmatory factor analysis (CFA). The identified bodily symptom dimensions were related to panic cognitions,
anxiety sensitivity and fear of suffocation by means of nonlinear structural equation modelling (SEM).
Results. CFA indicated a respiratory, a vestibular/mixed somatic and a cardiac dimension of the bodily symptom cri-
teria. These three factors were differentially associated with specific panic cognitions, different anxiety sensitivity facets
and suffocation fear.
Conclusions. Taking into account the dimensional structure of panic attack symptoms may help to increase the specifi-
city of the associations between the experience of panic attack symptoms and various panic related constructs.
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Introduction
According to the Diagnostic and Statistical Manual of
the American Psychiatric Association (DSM-IV; APA,
1994), a diagnosis of panic disorder (PD) requires the
experience of recurrent panic attacks, identified via
the sudden onset of intense apprehension or fear,
accompanied by at least four out of a list of ten bodily
and three cognitive symptoms. The conceptualization
of PD has changed considerably from DSM-III (APA,
1980) to DSM-IV, but the list of panic attack symptoms
(PAS) has only minimally changed. In DSM-IV, this
list comprises (1) palpitations, pounding heart, or
accelerated heart rate, (2) sweating (3) trembling
or shaking, (4) sensations of shortness of breath or
smothering, (5) feeling of choking, (6) chest pain or dis-
comfort, (7) nausea or abdominal distress, (8) feeling
dizzy, unsteady, lightheaded, or faint, (9) derealization
* Address for correspondence: I. Drenckhan, University of Münster,
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(feelings of unreality) or depersonalization (being de-
tached from oneself), (10) fear of losing control or
going crazy, (11) fear of dying, (12) paresthesias
(numbness or tingling sensations), (13) chills or hot
flushes. The recently published DSM-5 adopted this
symptom list with only one minor change in wording
(chills or heat sensations).
By this definition of a panic attack, all symptoms are
treated as equally important. However, some symp-
toms are endorsed consistently more frequently than
others. For example, in the Cross-National Panic
Study (CNPS; Briggs et al. 1993), a Japanese study
(Shioiri et al. 1996), a Spanish study (Segui et al.
1998), and a German study (Andor et al. 2008), at
least 83% of the patients reported palpitations, and
more than 71% shortness of breath. On the other
hand, paresthesias were endorsed by no more than
53% of the patients. These differences in the endorse-
ment rates of the symptoms and their postulated
emergence from different physiological systems have
stimulated both the search for panic patient subgroups
and for a dimensional structure of PAS. While subtyp-
ing approaches partition PD patients according to the
predominance of certain PAS (cf. review by Kircanski
et al. 2009), dimensional analyses focus on relating
PAS to underlying dimensions. Understanding the
dimensional structure of PAS is not only important
for the discussion of necessary changes for the PAS
list (cf. Craske et al. 2010) by either reducing the
number of PAS, or by adopting more PAS (i.e. to
accommodate culture-bound varieties of PAS, cf.
Lewis-Fernandez et al. 2010). It also allows specifying
current research findings on the connection between
PD and related risk factors, as described below.
We identified 11 studies of patients with PD that
reported dimensional solutions of PAS as listed in
DSM-III, DSM-III-R and DSM-IV. Four studies out of
these 11 employed a binary answer format for PAS,
but nevertheless subjected these to principal compo-
nent analysis (PCA; De Beurs et al. 1994; Bandelow
et al. 1996; Shioiri et al. 1996; Neerakal & Srinivasan,
2002). Because PCA has been found to produce biased
dimensional solutions when applied to binary vari-
ables (e.g. Kolenikov & Angeles, 2009), these studies
are not included in the following overview. Briggs
et al. (1993) also employed a binary format and
analysed their data with PCA, but fortunately
Roberson-Nay & Kendler (2011) re-analysed these
data with appropriate statistical methods.
Supplementary Table S1 lists the characteristics and
results of the remaining seven studies that analysed
PAS reports of patients with a diagnosis of PD (with
or without agoraphobia). With the exception of
Briggs et al. (1993), they employed severity ratings of
PAS with several answer categories. These ratings
were applied to the last attack (Briggs et al. 1993;
Sarp et al. 2010) or typical full panic attacks (Meuret
et al. 2006; not specified in the remaining four studies).
While Meuret et al. (2006) and Roberson-Nay &
Kendler (2011) used statistical methods which are not
biased by non-normal answer distributions, the re-
maining five studies employed PCA, which may pro-
duce biased results if linearity and normality
requirements are not met. The studies also varied
with respect to the nationality of the patients, the com-
position of the patient sample, the mode of assessment
of the panic symptoms and the number of symptoms
subjected to the dimensional analyses.
Meuret et al. (2006) identified a cardio-respiratory
factor associated with six PAS, defined by high
loadings of dyspnoea and chest pain, but also includ-
ing paresthesias and fear of dying. The second ‘auto-
nomic/somatic’ factor comprised the remaining
bodily symptoms. The third ‘cognitive’ factor was con-
stituted by the fears of going crazy and losing control,
and also derealization/depersonalization. By contrast,
Roberson-Nay & Kendler (2011) reported a pure ‘res-
piratory’ factor, which resembles the cardio-respiratory
factor of Meuret et al. (2006), but did not include tachy-
cardia. Instead tachycardia was allocated to a second
factor which corresponds to Meuret et al.’s (2006) auto-
nomic/somatic factor with respect to the other criteria
loading on it. Thus, the allocation of tachycardia is
the only major inconsistency, despite the considerable
differences between these two studies in sample com-
position and answer categories (cf. Supplementary
Table S1): both identified three dimensions which are
largely equivalent.
Cox et al. (1994) also found a ‘cardiorespiratory’
component that is virtually identical to the
cardio-respiratory factor of Meuret et al. (2006) with
the exception that paresthesias was assigned to a sep-
arate ‘dizziness’ component. This component is com-
prised of all the criteria that belong to the autonomic/
somatic factor of Meuret et al. (2006). The third factor
of Cox et al. (1994) combines fear of losing control
(0.82), fear of going crazy (0.82) and also feelings of un-
reality (0.47) and thus corresponds well to the cogni-
tive factor identified by Meuret et al. (2006). The
remaining studies claimed more than three dimen-
sions, rendering a direct comparison of their factor
structures with those of Meuret et al. (2006) and
Roberson-Nay & Kendler (2011) difficult. Segui et al.
(1998) identified a cardio-respiratory factor largely
identical to the factor of Meuret et al. (2006), but not in-
cluding choking. The symptoms combined in Meuret
et al.’s (2006) ‘autonomic/somatic’ factor appear in the
Segui et al. (1998) study distributed over three compo-
nents comprised of vestibular symptoms, other auto-
nomic symptoms and ‘general arousal’. However,
1676 I. Drenckhan et al.
https://doi.org/10.1017/S0033291714002803
Downloaded from https://www.cambridge.org/core. SLUB Dresden, on 19 Mar 2020 at 09:02:31, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
despite different numbers of dimensions and conse-
quently different allocations of symptoms, most of
the attack criteria covary in Segui et al. (1998) as in
the models of Meuret et al. (2006) and Roberson-Nay
& Kendler (2011). Only with respect to the cognitive
symptoms does the Segui et al. (1998) study differ. It
located fear of going crazy and derealization/deperso-
nalization on different factors.
Márquez et al. (2001) applied the same list of 14
DSM-III-R panic attack criteria as Segui et al. (1998).
They identified a first factor that overlaps with the
autonomous/somatic factor of Meuret et al. (2006),
but also includes palpitations. The second factor is
defined by respiratory symptoms, a third factor by ves-
tibular symptoms, and a fourth factor includes nausea
and depersonalization-derealization. By contrast to
most other studies, fear of dying and of going crazy
do not define a cognitive factor, but were allocated to
the respiratory factor. A Turkish study (Sarp et al.
2010) found a respiratory-cardiac factor, an auto-
nomic/somatic factor and a cognitive factor, rather
similar to the dimensional solution offered by Meuret
et al. (2006).
Pio-Abreu et al. (1998) only studied the disaggre-
gated DSM-IV bodily symptom criteria. They excluded
the cognitive symptoms from the dimensional analysis.
Most importantly, their five-component-solution sepa-
rated the respiratory and cardiovascular symptoms
present on the first factor of Meuret et al. (2006) by
assigning them to different components. The symp-
toms from the autonomic/somatic factor of Meuret
et al. (2006) are also distributed across two separate fac-
tors. Thus, the covariation among respiratory symp-
toms on the one hand, autonomic/somatic symptoms
on the other hand is at least partly preserved, despite
the more differentiated structure which is obtained
with the disaggregated criteria and a further expanded
symptom list.
To summarize, the model suggested by Meuret et al.
(2006) and by Roberson-Nay & Kendler (2011) for the
Briggs et al. (1993) data is largely in accord with the
results from several other studies with different assess-
ment and statistical methods. However, several of
the symptoms appear only loosely tied to particular
dimensions: While a respiratory symptom complex is
consistently found, the cardiovascular symptom cri-
teria are inconsistently allocated to different compo-
nents. Moreover, a vestibular factor, defined by the
symptoms of faintness and dizziness, is found in sev-
eral of the studies, while Meuret et al. (2006) subsumed
these symptoms under the autonomic/somatic factor.
Our first goal for this study was to further clarify the
dimensional structure of panic attack symptoms. We
will present a dimensional analysis for a sample of
German patients with PD with agoraphobia. We
followed the strategy of Pio-Abreu et al. (1998), confin-
ing this analysis to the ten bodily DSM-IV PAS.
Cognitive models consider bodily PAS and cata-
strophic cognitions as functionally different compo-
nents of panic attacks and postulate that the
perception of bodily PAS activates catastrophic cogni-
tions, which in turn provokes or amplifies further
panic symptoms (e.g. Clark, 1986). Pio-Abreu et al.
(1998) argue that simultaneous factor analyses or clus-
ter analyses of both bodily and psychological PAS are
not appropriate for this ‘vicious circle’ model, as the
cognitive symptoms are qualitatively different from
the bodily symptoms. Thus, we first determined the
factorial structure of the bodily symptoms of panic
attacks. We hypothesized a two-factor solution consist-
ing of a respiratory and a vestibular/mixed somatic fac-
tor. We tested whether a joint respiratory-cardiac
dimension or two separated dimensions better rep-
resent the respiratory and cardiac symptoms. A second
aim was to test the association between the resulting
dimensions and catastrophic cognitions in anxiety
situations. We expected strong associations between
respiratory symptoms and ‘fear of choking to death’,
and cardiac symptoms and ‘fear of a cardiac infarct’.
We expected less specific relationships between ‘fear
of going crazy’ or ‘fear of losing control’ and any of
the bodily symptoms of a panic attack dimensions.
These two cognitive symptoms either formed a factor
of their own or did not reach high loadings when sub-
sumed under a bodily symptom factor in the previous
analyses.
Reiss et al. (1986) defined anxiety sensitivity as
‘beliefs that the experience of anxiety/fear causes ill-
ness, embarrassment or additional anxiety’ (p. 1).
Anxiety sensitivity predicts the development of panic
attacks (Schmidt et al. 1997, 2006). Specifically the sub-
scale ‘physical sensations’ is associated with the course
of PD (Pérez Benitez et al. 2009) and the risk of de-
veloping panic attacks (Zinbarg et al. 2001; Schmidt
et al. 2006). Similarly, the construct ‘fear of suffocation’,
is not only linked to a higher rate of panic attacks in the
past, but also to a higher risk of experiencing exper-
imentally provoked (breathing through a narrow
straw) panic (Taylor & Rachman, 1994). In a student
sample, both anxiety sensitivity and suffocation fear
were correlated with anxiety and self-reported bodily
sensations experienced during experimental carbon
dioxide challenges (hyperventilation into a paper
bag), but suffocation fear was the better predictor
(McNally & Eke, 1996). Our third research question
concerned the relationship of anxiety sensitivity to
the bodily symptom dimensions. Our fourth research
aim was to examine the relationship of fear of suffo-
cation to the bodily symptom dimensions, especially
to a respiratory symptom dimension.
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Method
Participants and procedure
Outpatients diagnosed with PD with agoraphobia
(N = 369) were recruited in eight German treatment
centres as part of a multicentre trial named
‘Mechanisms of Action in cognitive behaviour therapy
(MAC)’. Participants were screened, signed an
informed consent, and were examined in a diagnostic
appointment to ascertain if they met the following in-
clusion criteria: (1) age 18–65 years, (2) a current pri-
mary diagnosis of PD with agoraphobia according to
DSM-IV-TR, (3) a clinical interview score518 on the
structured interview for the Hamilton Anxiety Rating
scale (Shear et al. 2001), (4) a Clinical Global
Impression scale (CGI) score54, (5) ability to regu-
larly attend treatment sessions. Exclusion criteria
were (1) psychotic or bipolar I disorder, (2) substance
abuse or dependence (alcohol, benzodiazepines or
other psychoactive substances), (3) current suicidal in-
tent, (4) borderline personality disorder, (5) current
psychotherapeutic or psycho-pharmacological treat-
ment, and (6) medical contraindications to exposure-
based cognitive behavioural therapy (CBT; for more
details see Gloster et al. 2009, 2011).
All measures considered in our study were meas-
ured during the initial diagnostic appointment
(Anxiety Sensitivity Index and Claustrophobia
Questionnaire) and baseline assessment (symptoms
of a panic attack and Agoraphobic Cognitions
Questionnaire), both of which preceded the beginning
of the treatment. Participants were seated in front of a
computer for the presentation and answering of the
measures. Missing data were minimized (N = 8) by a
computerized feedback algorithm that alerted patients
not to skip items (Gloster et al. 2009). The bodily PAS
answers were missing completely for one participant.
For all others (N = 7), only singular items were missing.
Nineteen patients were first assigned to a waiting con-
trol group before receiving therapy and answered the
questionnaires of the pre-assessment twice. In order
to avoid any influence of the repeated assessments
on our results, only the first measurement was in-
cluded in the analyses reported here resulting in the re-
maining 350 patients. The characteristics of the sample
are listed in Table 1.
Measures
Panic attack bodily symptoms
Participants rated how strongly (0 = not at all, to 4 =
extremely) they had experienced each of the ten
DSM-IV-TR bodily PAS during a recent typical panic
attack.
Agoraphobic Cognitions Questionnaire (ACQ)
The ACQ (Chambless et al. 1984) is a self-report-
questionnaire designed to capture catastrophic cogni-
tions activated during anxiety situations. It contains
14 items rated on a 5-point scale (1, thought never
occurs to 5, thought always occurs). Four of the ACQ
items were selected to assess the fear cognitions listed
among the DSM-IV panic attack criteria: item no. 4 ‘I
will have a heart attack’ and item no. 5 ‘I will choke
to death’ were substituted for the less specific ‘fear of
dying’ criterion. Item no. 8 ‘I will not be able to control
myself’ corresponds to the ‘fear of loss of control’ cri-
terion. Finally, item no. 11, ‘I am going to go crazy’ cor-
responds to the criterion ‘fear of going crazy’.
Anxiety Sensitivity Index (ASI)
The ASI (Reiss et al. 1986; German version by Alpers &
Pauli, 2001) assesses the tendency to fear anxiety-
related symptoms (e.g. increased heart rate, sweating)
because of their perceived aversive physical, social,
or mental consequences. The 16 phrases (e.g. ‘It
scares me when I feel faint’) are rated on 5-point scales
(0, very little to 4, very much). Previous studies
reported inconsistent results regarding the dimen-
sional structure of the ASI (see meta-analysis by
Olatunji & Wolitzky-Taylor, 2009; Naragon-Gainey,
2010). Therefore we investigated the factorial structure
of this measure anew in our patient sample with
Table 1. Sample characteristics with respect to demographics and
disorder (N = 350)
Characteristics
Age (years); mean (S.D.) 35.4 (10.8)
Gender (women) 75.4%
Partnership status (living together) 69.7%
Educational level (college or higher) 40.9%
Working status (full time employed) 58.6%
Panic disorder duration (years); mean (S.D.) 8.2 (9.7)
Panic attack frequency; mean (S.D.)
Last month 7.8 (12.4)
Last year 23.4 (20.1)
Co-morbid diagnoses
0 8%
1–2 43.4%
>2 48.6%
CGI total score, mean (S.D.) 5.2 (0.8)
Panic symptoms 3.9 (1.1)
Anxiety 4.7 (0.9)
Avoidance 4.5 (0.9)
Global functioning 4.5 (0.8)
CGI (Clinical Global Impression scale) ranging from 1
(normal) to 7 (amongst the most severely ill patients).
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nonlinear confirmatory factor analyses (CFA). The stat-
istically and substantively most convincing model
comprised three anxiety sensitivity dimensions. This
is in accordance with the model originally reported
by Zinbarg et al. (1997). The dimensions were labelled
‘physical concerns’ (3, 4, 6, 8–11, 14), ‘mental incapaci-
tation concerns’ (2, 12, 15, 16) and ‘social concerns’
(1, 5, 13). The model had acceptable model fit
[Comparative Fit Index (CFI) = 0.95, Tucker–Lewis
Index (TLI) = 0.93, Root Mean Square Error of Approxi-
mation (RMSEA) = 0.09) and after the inclusion of two
residual correlations between similar items (3–4 and
6–9) no remaining significant residual correlation. All
of the items yielded factor loadings50.53. The factor
inter-correlations varied between 0.60 (physical and
social) and 0.76 (physical and mental).
Claustrophobia Questionnaire (CLQ)
The 26-item CLQ (Radomsky et al. 2001) is a revised
and shortened version of the original CLQ (Rachman
& Taylor, 1993) comprising 36 items. The CLQ rates
the degree of anxiety aroused by different potentially
claustrophobic situations (5-point answer scales: 0,
not at all to 4, extremely). Since our sample consisted
of PD patients, not claustrophobia patients, we ana-
lysed the CLQ answers with nonlinear CFA in order
to test previously established two-factorial structure
reflecting suffocation fear (14 items) and restriction
fear (12 items) (Radomsky et al. 2001). The structural
analyses did not corroborate this two-factor structure.
Instead, results suggested that besides suffocation
fear (items 1, 4, 5–7, 13) and physical restrictions fear
(items 15–25) a third dimension (agoraphobic situa-
tions fear; items 2, 3, 8–12, 14, 26) has to be taken
into account in order to sufficiently explain CLQ
answer covariance in this patient sample. Factor load-
ings ranged from 0.45 to 0.87. Factor inter-correlations
ranged between 0.59 (restriction and suffocation) and
0.81 (restriction and agoraphobic situations). The
model fit of this three-factor model was acceptable
(RMSEA = 0.08, CFI = 0.96, TLI = 0.96).
Statistical analyses
All instruments used here provided ordinal answer
categories. As a consequence, the answers were pre-
sumably not multi-normally distributed and especially
not linearly related to underlying continuous dimen-
sions (latent variables; LV). Therefore all analyses re-
lied on nonlinear CFA based on the two-item
parameter (2P) Item Response Theory (IRT) model.
This model class has been specifically developed for
the appropriate handling of binary and ordinal depen-
dent variables and applies logistic instead of linear
regression to compute the associations between LVs
and their indicators. It prevents biased results when
the assumptions of multi-normality and linearity
made by conventional linear methods are not met.
The 2P-IRT-model analyses tetrachoric or polychoric
correlations estimated from the matrix of the
observed answer covariance. Its factor-analytical re-
parameterization requires that besides the item discri-
minations also the item difficulties are computed (for
further explications of this model class, see e.g.
Glöckner-Rist & Hoijtink, 2003). Muthén (2002) has
integrated this model class within a generalized struc-
tural equation modelling (SEM) framework in Mplus
(http://www.statmodel.com). All nonlinear continuous
CFA and SEM models were computed with this pro-
gram (version 6.0).
The following CFA models, which formalize differ-
ent assumptions about the factorial structure of the
10 DSM-IV bodily PAS, were investigated and
compared:
(1) A model positing two bodily PAS factors, i.e. a
cardio-respiratory and a vestibular/mixed somatic
factor following Meuret et al. (2006).
(2) A model excluding the cardiac symptoms from the
respiratory dimension by specifying three PAS fac-
tors (i.e. a respiratory, a vestibular/mixed somatic,
and in addition a separate cardiological factor).
All model computations were performed with a robust
mean and variance adjusted, weighted least squares
(WLSMV) estimator. The CFI, TLI, and RMSEA are
reported as descriptive indices of statistical fit. Values
>0.90 and >0.95 for the first two indices and values
<0.10 and close to 0.05 for the RMSEA are interpreted
as indicating an acceptable and good fit (cf. Bollen,
1989). Studies following the original recommendations
of Bollen (1989) show that for linear models a cut-off
criterion of 0.08 might be too lenient. Yet for nonlinear
models with several answer categories for indicators –
here even five – this criterion is appropriate (Yu, 2002).
In contrast to linear models, nonlinear models require
the estimation of significantly more parameters,
thereby necessarily increasing RMSEA values.
However, the substantive interpretability of the
models was also considered an important criterion to
judge the adequacy of the results. Bivariate residual
correlations were also considered in order to uncover
possible additional systematic influences on answer
processes.
The association of the PAS dimensions with the four
specific ACQ fear cognitions was tested by regressing
each of them on the final measurement model for the
bodily PAS criteria. The resulting regression coeffi-
cients may indicate specific associations of fear cogni-
tions to bodily PAS criteria dimensions.
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Results
Prevalence of bodily panic attack symptoms
A heart rate increase (item 3) was the most common
symptom. Nearly all of the patients (98.3%) endorsed
such an increase within a typical panic attack. The
next most frequent symptom endorsed was dizziness
(96%), followed by shortness of breath (92%), sweating
(88%), chest pain (85%), chills (84%), trembling (84%),
nausea (83%), and choking (79%). Paresthesia was the
least frequent symptom (69.5%). Palpations were
most often rated ‘extremely’ (highest answer category,
47%), whereas only 14% used this answer category to
rate paresthesias.
Confirmatory factor analysis of the bodily attack
symptom criteria
The allocation of the body symptoms and the factor
loadings for the respective model are presented in
Table 2. We first tested a two-dimensional model
representing Meuret et al.’s (2006) respiratory-cardiac
and mixed-somatic factors (M1). However, the fit of
this model was not acceptable (CFI = 0.83, TLI = 0.78,
RMSEA = 0.15). Moving symptom 8 (‘numbness’)
from the cardio-respiratory factor to the vestibular/
mixed somatic factor in accordance with the modifica-
tion indices improved the fit of M2 compared to M1,
but the fit was still not acceptable (CFI = 0.90, TLI =
0.87, RMSEA = 0.12).
The modification indices both for model 1 and
model 2 suggested a strong residual correlation be-
tween symptom 1 (shortness of breath) and symptom
2 (choking). Both criteria asked specifically and
uniquely about respiratory symptoms. We tested a
three-dimensional model (M3) retaining the vestibu-
lar/mixed somatic factor, but including separate respir-
atory and cardiac factors. This model explained the
answer covariance clearly better than the two-
dimensional models. CFI (0.96), TLI (0.95) and
RMSEA (0.07) were acceptable. The factor loadings
were all sufficiently large, with only one loading
slightly smaller than 0.40 (symptom 7, ‘nausea’). No re-
sidual correlation >0.20 was left, but the modification
indices suggested to include the residual correlation
between symptoms 5 (‘sweating’) and 9 (‘chills or hot
flushes’) into the model specification. This appeared
reasonable, as the two criteria presumably are func-
tionally related.
The three-factor model with the additional residual
correlation between symptoms 5 (‘sweating’) and 9
(‘chills or hot flushes’) (M4) reached a still better
model fit (CFI = 0.98, TLI = 0.97, RMSEA = 0.05),
although with smaller factor loadings of symptoms
5 (‘sweating’) and 9 (‘chills or hot flushes’) on the
vestibular/mixed somatic factor than before (cf.
Table 2). Whereas the correlation between the respirat-
ory and the cardiac factor remained the same, the cor-
relation between the vestibular/mixed somatic and the
cardiac factor (r = 0.62) and the vestibular/mixed so-
matic and the respiratory factor (r = 0.34) changed
slightly. This three-factor CFA model with one residual
correlation included achieved both the best fit and also
appeared substantively reasonable.
Relationship of the three panic attack criteria
dimensions to the specific ACQ fear cognitions
The three attack criteria dimensions established in the
measurement model (M4) were used to predict each
of the four ACQ items in turn. The resulting standar-
dized regression coefficients are listed in Table 3. As
expected, the fear of a heart attack (item 4) was pre-
dicted well by the cardiac dimension, and the fear of
choking to death (item 5) by the respiratory dimension.
Both the fear of a loss of control (item 8) and the fear of
going crazy (item 11) were predicted by the vestibular/
mixed somatic factor. The prediction of item 4 (heart
attack) by the cardiac factor and item 8 (loss of control)
by the vestibular/mixed somatic factor was ac-
companied by significant negative regression coeffi-
cients for both remaining factors, which added to the
specificity of the associations of these two items to
the bodily symptoms dimensions.
Relationship between the bodily symptom factors
and ASI and CLQ
Next, we examined the relationship between the bodily
PAS dimensions and the ASI and CLQ dimensions.
The model fit was good, with RMSEA = 0.05, TLI =
0.95, and CFI = 0.95. The correlations between the
PAS dimensions and the ASI and CLQ are shown in
Table 4. The three CLQ factors were significantly re-
lated only to the respiratory factor. The respiratory di-
mension was only modestly associated with the ASI
physical dimension and not associated with the other
ASI dimensions. By contrast, the vestibular/mixed so-
matic factor was linked to all ASI dimensions, includ-
ing the ASI social dimension. The cardiac dimension
correlated with the mental and physical dimensions
of the ASI, with the later having the strongest
association.
The bodily PAS factors were not significantly
correlated with age and gender. Moreover, corre-
lations between single bodily PAS criteria and gender
(r4 0.16) and age (r4−0.14) were rather low.
Including gender and age in the SEM relating the
bodily PAS dimensions to the CLQ and the ASI did
not change the pattern of associations. Furthermore,
site of treatment centres was not significantly
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correlated with any of the PAS dimensions (r4 0.18)
and was not a significant covariate in the PAS model.
Discussion
Comparing different models using CFA, we found that
the DSM-IV bodily PAS are best represented by a
three-factor solution consisting of respiratory, vestibu-
lar/mixed somatic, and cardiac dimensions. The ves-
tibular/mixed somatic dimension includes all the PAS
criteria allocated to the autonomic/somatic dimension
of Meuret et al. (2006). By contrast, our separate cardiac
and respiratory factors differ. A respiratory dimension
has been reported consistently by several studies.
Table 3. Standardized regression coefficients for the regression of four ACQ specific fear items on the three dimensions of the measurement
model for the DSM-IV bodily symptom attack criteria
I will have a heart
attack (item 4)
I will choke to
death (item 5)
I will not be able to
control myself (tem 8)
I am going to go
crazy (item 11)
Respiratory −0.28** 0.86*** 0.04 0.11
Cardiac 1.13*** −0.12 −0.40** −0.15
Vestibular/vestibular/mixed somatic −0.40** −0.06 0.61*** 0.39***
ACQ, Agoraphobic Cognitions Questionnaire.
** p < 0.01, *** p < 0.001.
Table 2. Item allocation and factor loadings for the tested dimensional models
M1 M2 M3 M4
R V/M R V/M R C V/M R C V/M
1. Shortness of breath 0.81 0.84 0.91 0.91
2. Choking 0.78 0.80 0.82 0.82
3. Palpitations 0.54 0.56 0.70 0.70
4. Chest pain 0.52 0.53 0.63 0.63
5. Sweating 0.66 0.66 0.66 0.53
6. Dizziness 0.58 0.59 0.59 0.61
7. Nausea 0.37 0.37 0.31 0.38
8. Numbness 0.50 0.58 0.58 0.61
9. Chills 0.74 0.73 0.72 0.61
10. Trembling 0.62 0.61 0.62 0.65
M1, Model representing Meuret’s dimensions; M2, item 8 (numbness) of model M1 relocated to the V/M factor; M3, Model
with separated cardiac and respiratory factor; M4 =M3 with one residual correlation; R, respiratory factor; V/M, vestibular/
mixed somatic factor; C, cardiac factor.
Table 4. Correlation between the factors of the SEM
CLQ ASI
Suffocation fear Agoraphobic fear Restriction fear Social Mental Physical
Respiratory 0.33* 0.24* 0.20* 0.07 0.07 0.18*
Cardiac 0.11 0.00 −0.03 0.10 0.21* 0.51*
Vestibular/mixed somatic 0.15 0.10 0.02 0.25* 0.39* 0.42*
SEM, Structural equation modelling, CLQ, Claustrophobia Questionnaire, ASI, Anxiety Sensitivity Index.
* p < 0.01.
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However, previous studies are inconsistent with re-
spect to the allocation of the PAS chest pain and palpi-
tations. Although chest pain also appeared to be
associated with the respiratory factor in our models,
the best fit was obtained when subsuming this symp-
tom together with palpitations under a separate car-
diac factor. Such a distinct cardiac factor is consistent
with Pio-Abreu et al. (1998).
The three dimensions of our model related differen-
tially to the specific anxiety constructs we introduced
(i.e. fear cognitions, claustrophobic fear and anxiety
sensitivity). This supports the notion that they did
not artificially result from over-extraction or reflect
reporting biases of the PD patients. The fear of having
a heart attack and choking to death were predicted
well by the cardiac and the respiratory dimensions, re-
spectively. In addition, the fear of having a heart attack
was also negatively related to the respiratory and the
vestibular/mixed somatic dimension, but less strongly.
This underscores the specificity of the association of
the heart attack cognition to the cardiac dimension.
The cognitions of losing control and going crazy
were both predicted by the vestibular/mixed somatic
factor and were not related to any of the other factors.
Incidentally, this pattern of associations advises
against including the cognitive PAS criteria together
with the bodily PAS into dimensional analyses. That
is, the PAS criterion of fear of dying apparently har-
bours two distinct fears, each tied closely to particular
bodily PAS. Arguably, fear of dying would load on the
respiratory and the cardiac dimension and thus hinder
their separation in dimensional analyses.
Differential associations of the three bodily PAS
dimensions were also found for anxiety sensitivity.
To date, no consensus exists regarding the association
between panic symptoms and anxiety sensitivity.
Panic symptoms have both been linked to ‘mental con-
cerns’ (Naragon-Gainey, 2010) and characterized as
‘almost entirely attributable to the fear of physical sen-
sations dimension of anxiety sensitivity’ (Olatunji &
Wolitzky-Taylor, 2009, p. 993). Our data seem to sup-
port both positions in that all three bodily PAS dimen-
sions were correlated with the physical concerns facet
of anxiety sensitivity, but were also differentially asso-
ciated with the remaining two facets of anxiety sensi-
tivity. The cardiac and the vestibular/mixed somatic
factor but not the respiratory factor were associated
with mental concerns, and only the vestibular/mixed
somatic factor was correlated with the social concerns
facet of anxiety sensitivity. It might be interesting for
future studies to examine the reasons why especially
vestibular symptoms are related to concerns with
mental incapacity.
Given the correlational nature of our data, we cannot
conclude whether the ASI or the suffocation scale is
better suited to predict panic attacks. However, our
results will contribute to this discussion. The CLQ fac-
tors including fear of suffocation were only correlated
with the respiratory dimension, whereas the ASI
physical concerns correlated highest with the cardiac
dimension, and the ASI mental and the social concerns
were both associated with the vestibular/mixed so-
matic dimension. Thus, it seems reasonable to expect
that the potential of these questionnaires to predict
panic attacks depend on the particular symptoms
prominent in an individuals’ typical panic attack. For
example, the CLQ should be a better predictor of
panic attacks for individuals with respiratory symp-
toms than for individuals with predominant cardiac
or vestibular PAS.
Our findings regarding the structure of the ASI are
consistent with previous dimensional analysis of the
ASI even though the ASI structure has previously not
been examined in a homogenous sample of PD
patients with agoraphobia. The CLQ was not explicitly
designed for the assessment of PD and its structure
had not previously been analysed based on ratings
by PD patients. Our failure to replicate the often-
reported two-dimensional structure may consequently
be due to our sample. That is, our third ‘agoraphobic
fear’ factor might be due to the answer covariance pro-
duced specifically by PD patients with agoraphobia.
Limitations
Our results are limited in several ways. Patients in our
study were asked to rate symptoms for a recent typical
panic attack. The results might have differed if we had
collected ratings of the most severe panic attacks.
Thus our findings are limited to typical panic
attacks. Further, it could be argued that all of the
symptoms – both physical and cognitive – reflect the
nature of panic (i.e. they are two factors that relate to
a higher order factor). Because we made the a priori de-
cision to follow the cognitive model of panic, we only
asked about physical symptoms during a typical panic
attack. Thus we were not able to directly test factor
analytic models of PAS dimensions including both
cognitive and physical symptoms.
Our model for the bodily PAS achieved a good fit
and performed well in terms of low residual correla-
tions. Nonetheless, the factor structure was not entirely
satisfactory. Two of the factors only consisted of two
items and at least three or four items have been recom-
mended to substantiate the estimation of a dimension
(Schmidt & Joiner, 2002). A serious limitation is in-
herent in the practice of subjecting PAS criteria consist-
ing of several symptoms to dimensional analyses.
When symptoms that tend to co-occur in a panic attack
are already combined in the PAS criteria, then they
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cannot contribute to the covariance between PAS. This
reduces the chances of adequately determining PAS
dimensions. Thus, future attempts to uncover the
structure of PAS should disaggregate the combined
symptoms into single symptoms and also include
more items to represent hitherto neglected symptom
domains (Ottaviani & Beck, 1987). For example,
Pio-Abreu et al. (1998) have both disaggregated the
DSM-IV PAS and included abdominal PAS in addition
to the bodily DSM-IV PAS and reported a separate ab-
dominal factor in addition to a respiratory and a cardio
factor.
Although the prevalence of PAS reported is compar-
able to previous studies with respect to their rank
order, our patients generally were among the more
severely affected patient samples described in the
literature. Only Cox et al. (1994) reported similarly
high symptom endorsement rates. This may be due
to agoraphobia being an inclusion criterion in our
study. Shioiri et al. (1996) and Segui et al. (1998) both
found a relationship between vestibular symptoms
and agoraphobia. Thus, the inclusion of only agora-
phobic patients might have increased symptom
reports. Meuret et al. (2006) reported that most of
their PD patients also had agoraphobia – in contrast
to less than half of the PD patients in the study of
Shioiri et al. (1996).
Further, and consistent with most studies of this nat-
ure, our data consisted of retrospective reports of the
symptoms. These might differ from the symptoms ex-
perienced by patients during a panic attack. For
example, symptoms linked to an individual’s fear
(e.g. palpitations when fearing a heart attack) may be
remembered as being extremely strong, while such
sensations as chills seem less threatening during the
panic attack and may therefore not explicitly be
remembered. De Beurs et al. (1994) collected data
from continuous self-monitoring of panic attacks and
compared these data to recalled symptoms. By com-
puting the concordance rates between response modal-
ities, the authors concluded that ‘many patients do not
have a consistent profile of panic symptoms’ (p. 43).
Thus further research on panic subtypes should in-
clude the use of self-monitoring data.
Final remarks
In summary, we found that the DSM-IV bodily panic
attack symptoms experienced during a typical panic
attack of PD patients are best described by three
dimensions: respiratory, cardiac and vestibular/mixed
somatic. These three dimensions are differentially re-
lated to specific fear cognitions, anxiety sensitivity,
and suffocation fear. Consideration of panic dimen-
sions and subtypes is therefore important for future
research trying to link PD to the ASI or other variables
of the cognitive model of panic attacks. For example,
Ehlers & Breuer (1996) remarked that an increased per-
ception of an individual’s heart rate could not be found
in general among PD patients, but rather for the sub-
group with cardiac neurosis. The present results, in
particular with regard to the differential association
of ASI and CLQ further support the notion that the
symptom profiles and the specific associated fears of
patients require specific therapeutic interventions
(e.g. specific symptom provocation exercises), which
should be further examined (cf. Gerlach & Neudeck,
2012).
Further research using other methods and samples
will be necessary to explore panic dimensions and
subtypes. A better description of symptom profiles
and associated constructs could improve the poor
detection rates of PD in the healthcare system
(cf. Sansone & Sansone, 2009; Fernández et al. 2012),
and support the development of more efficacious PD
treatment.
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